Form 4 for AVY Avery Dennison
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001127602-23-008702 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-03 | 2023-03-01 | AVY | Lovins Gregory | SVP, CFO | M - OptEx | $182.27 | +19.1K | 59.8K | +47% | +$3.48M |
| DM | 2023-03-03 | 2023-03-01 | AVY | Lovins Gregory | SVP, CFO | F - Tax | $182.27 | -7,752 | 58.9K | -12% | -$1.41M |
| DM | 2023-03-03 | 2023-03-01 | AVY | Lovins Gregory | SVP, CFO | M - OptEx | $0.00 | -19.1K | 1,571 | -92% | $0 |
| DM | 2023-03-03 | 2023-03-01 | AVY | Lovins Gregory | SVP, CFO | A - Grant | $0.00 | +17.5K | 4,545 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | M | A | 10,960 | $182.27 | 61,713 | D | — | — | (F1) Shares reflect the vesting of performance units granted in February 2020 at 200% of target, 50% based on our cumulative economic value added and 50% on our relative total stockholder return. |
| 2 | Common | Common Stock | 2023-03-01 | F | D | 599 | $182.27 | 62,071 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-01 | M | A | 1,334 | $182.27 | 62,670 | D | — | — | (F5) Shares reflect the vesting of the first tranche of market-leveraged stock units granted in February 2022 at 90% of target based on our absolute total stockholder return in excess of 10% during the 2022 performance period, plus dividend equivalents accrued during the period. |
| 4 | Common | Common Stock | 2023-03-01 | F | D | 500 | $182.27 | 61,336 | D | — | — | |
| 5 | Common | Common Stock | 2023-03-01 | M | A | 1,113 | $182.27 | 61,836 | D | — | — | (F4) Shares reflect the vesting of the second tranche of market-leveraged stock units granted in February 2021 at 121% of target based on our absolute total stockholder return in excess of 10% during the 2021-2022 performance period, plus dividend equivalents accrued during the period. |
| 6 | Common | Common Stock | 2023-03-01 | F | D | 4,916 | $182.27 | 56,797 | D | — | — | |
| 7 | Common | Common Stock | 2023-03-01 | M | A | 2,705 | $182.27 | 61,566 | D | — | — | (F3) Shares reflect the vesting of the third tranche of market-leveraged stock units granted in February 2020 at 164% of target based on our absolute total stockholder return in excess of 10% during the 2020-2022 performance period, plus dividend equivalents accrued during the period. |
| 8 | Common | Common Stock | 2023-03-01 | F | D | 843 | $182.27 | 60,723 | D | — | — | |
| 9 | Common | Common Stock | 2023-03-01 | M | A | 2,958 | $182.27 | 59,755 | D | — | — | (F2) Shares reflect the vesting of the fourth tranche of market-leveraged stock units granted in February 2019 at 200% of target based on our absolute total stockholder return in excess of 10% during the 2019-2022 performance period, plus dividend equivalents accrued during the period. |
| 10 | Common | Common Stock | 2023-03-01 | F | D | 894 | $182.27 | 58,861 | D | — | — | |
| 11 | Derivative | 2020 PU Award | 2023-03-01 | M | D | 10,960 | $0.00 | 0 | D | $0.00 · 2023-02-27 to 2023-03-01 | 10,960 Common Stock | (F1) Shares reflect the vesting of performance units granted in February 2020 at 200% of target, 50% based on our cumulative economic value added and 50% on our relative total stockholder return. |
| 12 | Derivative | 2019 MSU Award | 2023-03-01 | M | D | 2,958 | $0.00 | 0 | D | $0.00 · 2020-02-28 to 2023-03-01 | 2,958 Common Stock | (F2) Shares reflect the vesting of the fourth tranche of market-leveraged stock units granted in February 2019 at 200% of target based on our absolute total stockholder return in excess of 10% during the 2019-2022 performance period, plus dividend equivalents accrued during the period. |
| 13 | Derivative | 2021 MSU Award | 2023-03-01 | M | D | 1,113 | $0.00 | 1,788 | D | $0.00 · 2022-03-01 to 2025-03-01 | 1,113 Common Stock | (F4) Shares reflect the vesting of the second tranche of market-leveraged stock units granted in February 2021 at 121% of target based on our absolute total stockholder return in excess of 10% during the 2021-2022 performance period, plus dividend equivalents accrued during the period. |
| 14 | Derivative | 2022 MSU Award | 2023-03-01 | M | D | 1,334 | $0.00 | 4,372 | D | $0.00 · 2023-03-01 to 2026-03-01 | 1,334 Common Stock | (F5) Shares reflect the vesting of the first tranche of market-leveraged stock units granted in February 2022 at 90% of target based on our absolute total stockholder return in excess of 10% during the 2022 performance period, plus dividend equivalents accrued during the period. |
| 15 | Derivative | 2023 Special RSU Award | 2023-03-01 | A | A | 8,230 | $0.00 | 8,230 | D | $0.00 · 2026-03-01 to 2026-03-01 | 8,230 Common Stock | (F8) The restricted stock units cliff vest on the third anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 16 | Derivative | 2023 PU Award | 2023-03-01 | A | A | 4,686 | $0.00 | 4,686 | D | $0.00 · 2026-03-01 to 2026-03-01 | 4,686 Common Stock | (F7) Performance units vest, if at all, at the end of fiscal year 2025, provided certain performance objectives are met as determined by the Compensation Committee in February 2026. Each performance unit represents a contingent right to receive one share of common stock |
| 17 | Derivative | 2023 MSU Award | 2023-03-01 | A | A | 4,545 | $0.00 | 4,545 | D | $0.00 · 2024-03-01 to 2027-03-01 | 4,545 Common Stock | (F6) Market-leveraged stock units vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on the percentage change in the Company's stock price, plus dividend equivalents accrued during the vesting period. Each market-leveraged stock unit represents a contingent right to receive one share of common stock, plus accrued dividend equivalents. |
| 18 | Derivative | 2020 MSU Award | 2023-03-01 | M | D | 2,705 | $0.00 | 1,571 | D | $0.00 · 2021-02-27 to 2024-03-01 | 2,705 Common Stock | (F3) Shares reflect the vesting of the third tranche of market-leveraged stock units granted in February 2020 at 164% of target based on our absolute total stockholder return in excess of 10% during the 2020-2022 performance period, plus dividend equivalents accrued during the period. |